134 CHAPTER 6 Supplementary data Supplementary Figure 1 | (A) the number of BCRh clones (B) the number of dominant BCRh clones and (C) the impact of dominant BCRh clones at screening for RA-risk (RTX treated), RA-risk (Placebo treated) and RA-risk (untreated). (D) the number of BCRh clones, (E) number of dominant BCRh clones and (F) impact of dominant BCRh clones at screening in healthy controls and RA-risk individuals. Data are presented as median and interquartile range. Supplementary figure 2 | The number of BCRh clones during follow-up in (A) the PRAIRI study and (B) DOMINO study. Data are presented as median and interquartile range.
RkJQdWJsaXNoZXIy MTk4NDMw